STERIS plc (Ireland) (STE) reported $6.17B of revenue for the twelve months ended Sep 30, 2026. That is up 8.1% from the year before. Revenue for fiscal 2026 was $5.94B.

Yes. STERIS plc (Ireland) earned $826.90M in net income for the twelve months ended Sep 30, 2026, a net margin of 13.4%.

How much cash and debt does STE have?

STERIS plc (Ireland) reported $531.10M in cash and cash equivalents and $1.89B of debt on its most recent balance sheet in SEC filings.

How fast is STE revenue growing?

STERIS plc (Ireland)'s revenue changed +8.7% in fiscal 2026, to $5.94B. Its compound annual growth rate was +13.8% over 5 years.

What is STE gross margin?

STERIS plc (Ireland)'s gross profit was $2.75B on $6.17B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 44.6%.

What is STE free cash flow?

STERIS plc (Ireland) generated $937.20M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.29B less capital expenditures.

What is STE earnings per share?

Diluted earnings per share were $8.43 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did STE last report financial results?

The latest statements here come from STERIS plc (Ireland)'s 10-Q filed on Nov 5, 2026, covering the period ended Sep 30, 2026.

Where does this STE financial data come from?

Quantisnow builds these statements from the structured XBRL data STERIS plc (Ireland) files with the SEC. It is provided for information only and is not investment advice.

Financials · STE

STERIS plc (Ireland) (STE) financials

For the twelve months ended Sep 30, 2026, STERIS plc (Ireland) reported $6.17B of revenue and $826.90M of net income.

Revenue, TTM: $6.17B
Revenue growth, YoY: +8.1%
Net income, TTM: $826.90M
Net income growth, YoY: +20.1%
Net margin: 13.4%
Free cash flow, TTM: $937.20M
EPS, diluted, TTM: $8.43
EPS growth, YoY: +21.1%
Cash: $531.10M
Total debt: $1.89B
P/E: 29.75
P/S: 3.99
Market cap: $24.60B

Annual revenue$5.94B

FY2017FY2026

Annual net income$782.30M

FY2017FY2026

Annual free cash flow$972.40M

FY2017FY2026

STE revenue and earnings growth

STE revenueQ2 2027$1.59B

Quarter YoY: +8.8%
QoQ: +6.4%
FY YoY: +8.7%
5Y CAGR: +13.8%

STE revenue was $1.59B in fiscal Q2 2027 (ended Sep 30, 2026), up 8.8% from a year earlier and up 6.4% from the prior quarter. For the full fiscal 2026 it was $5.94B, up 8.7% from fiscal 2025. Compound annual growth was +13.8% over 5 years. It rose in each of the last 9 fiscal years. Fiscal 2026 is the highest of the 10 fiscal years on file.

STE net incomeQ2 2027$213.70M

Quarter YoY: +11.4%
QoQ: +6.8%
FY YoY: +27.3%
5Y CAGR: +14.5%

STE net income was $213.70M in fiscal Q2 2027 (ended Sep 30, 2026), up 11.4% from a year earlier and up 6.8% from the prior quarter. For the full fiscal 2026 it was $782.30M, up 27.3% from fiscal 2025. Compound annual growth was +14.5% over 5 years. It rose in 6 of the last 9 fiscal years. Fiscal 2026 is the highest of the 10 fiscal years on file.

STE EPSQ2 2027$2.19

Quarter YoY: +12.9%
QoQ: +7.4%
FY YoY: +27.9%
5Y CAGR: +11.4%

STE diluted EPS was $2.19 in fiscal Q2 2027 (ended Sep 30, 2026), up 12.9% from a year earlier and up 7.4% from the prior quarter. For the full fiscal 2026 it was $7.93, up 27.9% from fiscal 2025. Compound annual growth was +11.4% over 5 years.

STE free cash flowQ2 2027$212.90M

Quarter YoY: +5.8%
QoQ: -23.9%
FY YoY: +25.0%
5Y CAGR: +16.6%

STE free cash flow was $212.90M in fiscal Q2 2027 (ended Sep 30, 2026), up 5.8% from a year earlier and down 23.9% from the prior quarter. For the full fiscal 2026 it was $972.40M, up 25.0% from fiscal 2025. Compound annual growth was +16.6% over 5 years. It rose in 7 of the last 9 fiscal years. Fiscal 2026 is the highest of the 10 fiscal years on file.

Export CSV

Income statement

Income statement
Line item	FY2026 Mar 31, 2026	FY2025 Mar 31, 2025	FY2024 Mar 31, 2024	FY2023 Mar 31, 2023	FY2022 Mar 31, 2022	FY2021 Mar 31, 2021	FY2020 Mar 31, 2020	FY2019 Mar 31, 2019	FY2018 Mar 31, 2018	FY2017 Mar 31, 2017
Revenue	$5.94B	$5.46B	$5.14B	$4.54B	$4.22B	$3.11B	$3.03B	$2.78B	$2.62B	$2.61B
Cost of revenue	$3.31B	$3.06B	$2.92B	$2.56B	$2.34B	$1.76B	$1.71B	$1.61B	$1.53B	$1.59B
Gross profit	$2.63B	$2.40B	$2.22B	$1.98B	$1.88B	$1.34B	$1.32B	$1.17B	$1.09B	$1.03B
Research and development	$112.90M	$107.60M	$103.70M	$98.48M	$86.66M	$66.33M	$65.55M	$63.04M	$60.78M	$59.40M
Selling, general and admin	$1.41B	$1.33B	$1.25B	$1.09B	$1.32B	$731.32M	$716.73M	$669.94M	$631.98M	$682.04M
Operating income	$1.10B	$866.60M	$836.10M	$791.10M	$477.81M	$548.37M	$537.05M	$411.02M	$399.88M	$226.21M
Interest expense	$60.70M	$86.30M	$144.40M	$107.96M	$89.49M	$37.18M	$40.28M	$45.02M	$50.63M	$44.52M
Pre-tax income	$1.05B	$796.20M	$702.80M	$680.27M	$366.80M	$517.53M	$498.75M	$369.03M	$354.98M	$184.65M
Income tax	$262.20M	$184.70M	$149.50M	$124.07M	$82.34M	$120.66M	$90.89M	$64.28M	$63.36M	$74.02M
Net income	$782.30M	$614.60M	$378.20M	$107.03M	$243.89M	$397.40M	$407.66M	$303.72M	$290.92M	$109.97M
EPS, basic	$7.97	$6.24	$3.83	$1.07	$2.50	$4.66	$4.81	$3.59	$3.42	$1.29
EPS, diluted	$7.93	$6.20	$3.81	$1.07	$2.48	$4.63	$4.76	$3.55	$3.39	$1.28
Diluted shares	98.7M	99.1M	99.4M	100.2M	98.3M	85.9M	85.6M	85.5M	85.7M	86.1M

Balance sheet

Balance sheet
Line item	FY2026 Mar 31, 2026	FY2025 Mar 31, 2025	FY2024 Mar 31, 2024	FY2023 Mar 31, 2023	FY2022 Mar 31, 2022	FY2021 Mar 31, 2021	FY2020 Mar 31, 2020	FY2019 Mar 31, 2019	FY2018 Mar 31, 2018	FY2017 Mar 31, 2017
Cash and equivalents	$439.60M	$171.70M	$207.00M	$208.40M	$348.32M	$220.53M	$319.58M	$220.63M	$201.53M	$282.92M
Receivables	$1.09B	$1.04B	$1.01B	$864.99M	$799.04M	$609.41M	$586.48M	$564.83M	$528.07M	-
Inventory	$631.80M	$581.30M	$674.53M	$604.41M	$575.00M	$315.07M	$263.54M	$208.24M	$205.73M	-
Current assets	$2.39B	$2.00B	$2.87B	$2.01B	$1.88B	$1.21B	$1.22B	$1.05B	$989.66M	-
Goodwill	$4.19B	$4.10B	$4.07B	$3.88B	$3.94B	$3.03B	$2.36B	$2.32B	$2.43B	$2.23B
Total assets	$10.74B	$10.15B	$11.06B	$10.82B	$11.42B	$6.57B	$5.44B	$5.07B	$5.20B	-
Current liabilities	$1.15B	$1.02B	$931.13M	$861.84M	$922.22M	$577.92M	$503.61M	$465.20M	$398.46M	-
Short-term debt	$118.90M	$125.00M	$85.94M	$60.00M	$142.88M	$0	$0	-	-	-
Long-term debt	$1.81B	$1.92B	$3.12B	$3.02B	$2.95B	$1.65B	$1.15B	$1.18B	$1.32B	-
Total debt	$1.93B	$2.04B	$3.21B	$3.08B	$3.09B	$1.65B	$1.15B	$1.18B	$1.32B	-
Total liabilities	$3.54B	$3.53B	$4.75B	$4.73B	$4.88B	$2.68B	$2.02B	$1.89B	$1.98B	-
Shareholders' equity	$7.18B	$6.62B	$6.32B	$6.09B	$6.54B	$3.89B	$3.42B	$3.20B	$3.22B	$2.81B

Cash flow

Cash flow
Line item	FY2026 Mar 31, 2026	FY2025 Mar 31, 2025	FY2024 Mar 31, 2024	FY2023 Mar 31, 2023	FY2022 Mar 31, 2022	FY2021 Mar 31, 2021	FY2020 Mar 31, 2020	FY2019 Mar 31, 2019	FY2018 Mar 31, 2018	FY2017 Mar 31, 2017
Operating cash flow	$1.34B	$1.15B	$973.30M	$756.95M	$684.81M	$689.64M	$590.56M	$539.50M	$457.63M	$424.09M
Capital expenditures	$369.00M	$370.10M	$360.30M	$361.97M	$287.56M	$239.26M	$214.52M	$189.72M	$165.46M	$172.90M
Free cash flow	$972.40M	$778.00M	$613.00M	$394.98M	$397.25M	$450.38M	$376.04M	$349.79M	$292.18M	$251.19M
Investing cash flow	-$512.50M	$388.80M	-$887.40M	-$383.33M	-$666.56M	-$1.15B	-$319.74M	-$213.22M	-$203.83M	-$104.25M
Financing cash flow	-$568.20M	-$1.57B	-$85.20M	-$498.72M	$115.83M	$345.62M	-$163.15M	-$294.79M	-$356.18M	-$267.10M
Dividends paid	$241.80M	$219.90M	$200.60M	$183.50M	$163.17M	$133.84M	$123.03M	$112.50M	$102.93M	$93.19M
Share repurchases	$235.50M	$211.30M	$11.80M	$308.56M	$55.78M	$14.65M	$51.24M	$81.49M	$65.48M	$97.51M
Stock-based compensation	$61.70M	$57.40M	$56.50M	$38.95M	$57.66M	$25.97M	$23.81M	$23.96M	$22.19M	$18.79M
Depreciation and amortization	$486.50M	$476.20M	$565.20M	$552.90M	$553.10M	$219.24M	$197.24M	$225.92M	$178.33M	$188.14M

Key ratios

Key ratios
Line item	FY2026 Mar 31, 2026	FY2025 Mar 31, 2025	FY2024 Mar 31, 2024	FY2023 Mar 31, 2023	FY2022 Mar 31, 2022	FY2021 Mar 31, 2021	FY2020 Mar 31, 2020	FY2019 Mar 31, 2019	FY2018 Mar 31, 2018	FY2017 Mar 31, 2017
Revenue growth, YoY	8.7%	6.2%	13.3%	7.4%	35.9%	2.5%	8.9%	6.2%	0.3%	-
Net income growth, YoY	27.3%	62.5%	253.4%	-56.1%	-38.6%	-2.5%	34.2%	4.4%	164.6%	-
EPS growth, YoY	27.9%	62.7%	256.1%	-56.9%	-46.4%	-2.7%	34.1%	4.7%	164.8%	-
Gross margin	44.2%	44.0%	43.2%	43.7%	44.6%	43.2%	43.6%	42.2%	41.7%	39.3%
Operating margin	18.6%	15.9%	16.3%	17.4%	11.3%	17.6%	17.7%	14.8%	15.3%	8.7%
Net margin	13.2%	11.3%	7.4%	2.4%	5.8%	12.8%	13.5%	10.9%	11.1%	4.2%
Free cash flow margin	16.4%	14.3%	11.9%	8.7%	9.4%	14.5%	12.4%	12.6%	11.2%	9.6%
Return on equity	10.9%	9.3%	6.0%	1.8%	3.7%	10.2%	11.9%	9.5%	9.0%	3.9%
Return on assets	7.3%	6.1%	3.4%	1.0%	2.1%	6.0%	7.5%	6.0%	5.6%	-
Current ratio	2.09	1.96	3.08	2.33	2.04	2.10	2.43	2.27	2.48	-
Debt to equity	0.27	0.31	0.51	0.51	0.47	0.42	0.34	0.37	0.41	-

Income statement

Income statement
Line item	Q2 2027 Sep 30, 2026	Q1 2027 Jun 30, 2026	Q4 2026* Mar 31, 2026	Q3 2026 Dec 31, 2025	Q2 2026 Sep 30, 2025	Q1 2026 Jun 30, 2025	Q4 2025* Mar 31, 2025	Q3 2025 Dec 31, 2024	Q2 2025 Sep 30, 2024	Q1 2025 Jun 30, 2024	Q4 2024 Mar 31, 2024	Q3 2024 Dec 31, 2023
Revenue	$1.59B	$1.49B	$1.59B	$1.50B	$1.46B	$1.39B	$1.48B	$1.37B	$1.33B	$1.28B	$1.42B	$1.30B
Cost of revenue	$877.80M	$808.60M	$891.20M	$840.70M	$814.40M	$763.10M	$839.40M	$760.20M	$750.10M	$707.10M	$836.49M	$737.70M
Gross profit	$710.80M	$684.20M	$697.10M	$655.50M	$645.90M	$628.00M	$641.20M	$610.30M	$578.80M	$572.40M	$582.90M	$560.03M
Research and development	$31.50M	$28.60M	$28.80M	$29.50M	$28.20M	$26.40M	$27.60M	$27.40M	$27.00M	$25.60M	$27.48M	$25.25M
Selling, general and admin	$366.00M	$369.70M	$351.80M	$352.30M	$349.70M	$353.80M	$333.90M	$335.50M	$329.30M	$335.60M	$309.05M	$308.30M
Operating income	$294.30M	$285.80M	$316.80M	$273.20M	$265.80M	$246.00M	$216.10M	$245.30M	$219.70M	$185.50M	$220.32M	$226.47M
Interest expense	$11.20M	$15.80M	$15.10M	$14.90M	$14.90M	$15.90M	$17.20M	$19.10M	$19.70M	$30.40M	$36.16M	$38.95M
Pre-tax income	$288.00M	$273.50M	$304.50M	$257.80M	$253.10M	$231.90M	$197.30M	$228.70M	$194.90M	$175.20M	$190.57M	$189.60M
Income tax	$73.90M	$72.50M	$84.20M	$63.50M	$60.60M	$53.90M	$50.50M	$55.40M	$43.50M	$35.30M	$37.28M	$41.00M
Net income	$213.70M	$200.10M	$220.20M	$192.90M	$191.90M	$177.40M	$145.60M	$173.50M	$150.00M	$145.40M	-$1.38M	$140.74M
EPS, basic	$2.20	$2.05	$2.26	$1.96	$1.95	$1.80	$1.49	$1.76	$1.52	$1.47	-$0.01	$1.42
EPS, diluted	$2.19	$2.04	$2.24	$1.96	$1.94	$1.79	$1.48	$1.75	$1.51	$1.46	-$0.01	$1.42
Diluted shares	97.6M	97.9M	-	98.6M	98.8M	98.8M	-	98.9M	99.2M	99.4M	-	99.4M

Balance sheet

Balance sheet
Line item	Q2 2027 Sep 30, 2026	Q1 2027 Jun 30, 2026	Q4 2026* Mar 31, 2026	Q3 2026 Dec 31, 2025	Q2 2026 Sep 30, 2025	Q1 2026 Jun 30, 2025	Q4 2025* Mar 31, 2025	Q3 2025 Dec 31, 2024	Q2 2025 Sep 30, 2024	Q1 2025 Jun 30, 2024	Q4 2024 Mar 31, 2024	Q3 2024 Dec 31, 2023
Cash and equivalents	$531.10M	$482.30M	$439.60M	$423.70M	$319.20M	$279.70M	$171.70M	$155.20M	$172.20M	$198.30M	$207.00M	$195.59M
Receivables	$1.01B	$1.01B	$1.09B	$990.60M	$947.30M	$947.10M	$1.04B	$915.20M	$923.34M	$892.61M	$1.01B	$964.02M
Inventory	$737.00M	$712.10M	$631.80M	$673.50M	$658.50M	$641.20M	$581.30M	$649.56M	$688.93M	$698.59M	$674.53M	$855.62M
Current assets	$2.48B	$2.45B	$2.39B	$2.29B	$2.11B	$2.06B	$2.00B	$1.90B	$1.94B	$1.94B	$2.87B	$2.22B
Goodwill	$4.18B	$4.19B	$4.19B	$4.23B	$4.22B	$4.22B	$4.10B	$4.04B	$4.15B	$4.06B	$4.07B	$4.11B
Total assets	$10.71B	$10.74B	$10.74B	$10.59B	$10.41B	$10.40B	$10.15B	$10.01B	$10.24B	$10.11B	$11.06B	$11.44B
Current liabilities	$1.21B	$1.28B	$1.15B	$922.30M	$888.90M	$926.60M	$1.02B	$891.12M	$805.48M	$834.36M	$931.13M	$913.69M
Short-term debt	$243.10M	$243.40M	$118.90M	$0	$0	$0	$125.00M	$125.00M	$80.00M	$80.00M	$85.94M	$78.44M
Long-term debt	$1.65B	$1.65B	$1.81B	$1.90B	$1.90B	$1.90B	$1.92B	$2.04B	$2.16B	$2.24B	$3.12B	$3.23B
Total debt	$1.89B	$1.89B	$1.93B	$1.90B	$1.90B	$1.90B	$2.04B	$2.16B	$2.24B	$2.32B	$3.21B	$3.31B
Total liabilities	$3.44B	$3.51B	$3.54B	$3.42B	$3.39B	$3.44B	$3.53B	$3.58B	$3.63B	$3.74B	$4.75B	$5.01B
Shareholders' equity	$7.26B	$7.22B	$7.18B	$7.15B	$7.02B	$6.97B	$6.62B	$6.43B	$6.61B	$6.37B	$6.32B	$6.43B

Cash flow

Cash flow
Line item	Q2 2027 Sep 30, 2026	Q1 2027 Jun 30, 2026	Q4 2026* Mar 31, 2026	Q3 2026 Dec 31, 2025	Q2 2026 Sep 30, 2025	Q1 2026 Jun 30, 2025	Q4 2025* Mar 31, 2025	Q3 2025 Dec 31, 2024	Q2 2025 Sep 30, 2024	Q1 2025 Jun 30, 2024	Q4 2024 Mar 31, 2024	Q3 2024 Dec 31, 2023
Operating cash flow	$289.00M	$367.10M	$335.40M	$298.20M	$287.80M	$420.00M	$260.80M	$332.80M	$250.80M	$303.70M	$254.83M	$291.24M
Capital expenditures	$76.10M	$87.50M	$90.20M	$98.70M	$86.50M	$93.60M	$70.90M	$89.20M	$101.90M	$108.10M	$91.47M	$118.94M
Free cash flow	$212.90M	$279.60M	$245.20M	$199.50M	$201.30M	$326.40M	$189.90M	$243.60M	$148.90M	$195.60M	$163.36M	$172.31M
Investing cash flow	-$76.10M	-$108.50M	-$217.20M	-$98.50M	-$88.30M	-$108.50M	-$69.80M	-$123.90M	-$105.30M	$687.80M	-$95.65M	-$118.92M
Financing cash flow	-$163.50M	-$213.50M	-$97.90M	-$98.00M	-$159.20M	-$213.10M	-$178.10M	-$214.40M	-$181.00M	-$998.90M	-$143.78M	-$197.99M
Dividends paid	$67.00M	$61.40M	$61.80M	$61.90M	$61.90M	$56.20M	$56.00M	$56.20M	$56.30M	$51.40M	$51.43M	$51.38M
Share repurchases	$100.40M	$115.50M	$74.30M	$50.10M	$100.50M	$10.60M	$200.0K	$100.50M	$46.42M	$64.20M	$360.0K	$2.23M
Stock-based compensation	$21.70M	$12.80M	$12.90M	$15.70M	$21.20M	$11.90M	$9.80M	$15.30M	$20.80M	$11.50M	$8.91M	$15.29M
Depreciation and amortization	$125.60M	$123.80M	$123.40M	$122.00M	$121.70M	$119.40M	$122.30M	$125.90M	$115.30M	$112.70M	$134.39M	$140.63M

Key ratios

Key ratios
Line item	Q2 2027 Sep 30, 2026	Q1 2027 Jun 30, 2026	Q4 2026* Mar 31, 2026	Q3 2026 Dec 31, 2025	Q2 2026 Sep 30, 2025	Q1 2026 Jun 30, 2025	Q4 2025* Mar 31, 2025	Q3 2025 Dec 31, 2024	Q2 2025 Sep 30, 2024	Q1 2025 Jun 30, 2024	Q4 2024 Mar 31, 2024	Q3 2024 Dec 31, 2023
Revenue growth, YoY	8.8%	7.3%	7.3%	9.2%	9.9%	8.7%	4.3%	5.6%	7.3%	8.1%	10.8%	16.7%
Net income growth, YoY	11.4%	12.8%	51.2%	11.2%	27.9%	22.0%	-	23.3%	30.1%	17.7%	-	13.7%
EPS growth, YoY	12.9%	14.0%	51.4%	12.0%	28.5%	22.6%	-	23.2%	30.2%	16.8%	-	14.5%
Gross margin	44.7%	45.8%	43.9%	43.8%	44.2%	45.1%	43.3%	44.5%	43.6%	44.7%	41.1%	43.2%
Operating margin	18.5%	19.1%	19.9%	18.3%	18.2%	17.7%	14.6%	17.9%	16.5%	14.5%	15.5%	17.5%
Net margin	13.5%	13.4%	13.9%	12.9%	13.1%	12.8%	9.8%	12.7%	11.3%	11.4%	-0.1%	10.8%
Free cash flow margin	13.4%	18.7%	15.4%	13.3%	13.8%	23.5%	12.8%	17.8%	11.2%	15.3%	11.5%	13.3%
Current ratio	2.05	1.91	2.09	2.48	2.37	2.22	1.96	2.13	2.41	2.33	3.08	2.43
Debt to equity	0.26	0.26	0.27	0.27	0.27	0.27	0.31	0.34	0.34	0.36	0.51	0.51

Source: XBRL data STERIS plc (Ireland) files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

STE peers

Company	Revenue	Growth	Net income	Net margin	Market cap
STE	$6.17B	+8.1%	$826.90M	13.4%	$24.60B
ISRGIntuitive Surgical Inc.	$11.58B	+20.5%	$2.96B	25.5%	$156.96B
EWEdwards Lifesciences Corporation	$6.67B	+13.4%	$1.02B	15.3%	$58.73B
ZBHZimmer Biomet Holdings Inc.	$8.57B	+7.0%	$767.30M	9.0%	$19.98B
MASMasco Corporation	$7.67B	+0.9%	$926.00M	12.1%	$15.85B
SNNSmith & Nephew SNATS Inc.	$6.16B	+6.1%	$625.00M	10.1%	$13.04B
ALGNAlign Technology Inc.	$4.16B	+4.4%	$491.87M	11.8%	$11.70B
AITApplied Industrial Technologies Inc.	$5.06B	+8.5%	$424.12M	8.4%	$10.35B
POOLPool Corporation	$5.45B	+2.9%	$395.95M	7.3%	$7.56B

STE FAQ

9 questions

What is STE revenue?
STERIS plc (Ireland) (STE) reported $6.17B of revenue for the twelve months ended Sep 30, 2026. That is up 8.1% from the year before. Revenue for fiscal 2026 was $5.94B.
Is STE profitable?
Yes. STERIS plc (Ireland) earned $826.90M in net income for the twelve months ended Sep 30, 2026, a net margin of 13.4%.
How much cash and debt does STE have?
STERIS plc (Ireland) reported $531.10M in cash and cash equivalents and $1.89B of debt on its most recent balance sheet in SEC filings.
How fast is STE revenue growing?
STERIS plc (Ireland)'s revenue changed +8.7% in fiscal 2026, to $5.94B. Its compound annual growth rate was +13.8% over 5 years.
What is STE gross margin?
STERIS plc (Ireland)'s gross profit was $2.75B on $6.17B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 44.6%.
What is STE free cash flow?
STERIS plc (Ireland) generated $937.20M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.29B less capital expenditures.
What is STE earnings per share?
Diluted earnings per share were $8.43 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did STE last report financial results?
The latest statements here come from STERIS plc (Ireland)'s 10-Q filed on Nov 5, 2026, covering the period ended Sep 30, 2026.
Where does this STE financial data come from?
Quantisnow builds these statements from the structured XBRL data STERIS plc (Ireland) files with the SEC. It is provided for information only and is not investment advice.